CEO James Walesa to Provide Organizational and Industry Update at Conference
San Antonio, Texas, Sept. 13, 2023 (GLOBE NEWSWIRE) — Clearday (OTCQX: CLRD), an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector,, is pleased to announce they have been invited to present at the upcoming SHARE Series conference.
On Monday, September 18, 2023 at 1230pm EDT CEO James Walesa will present at the upcoming SHARE Fireside Chat Series via a virtual presentation.
James Walesa, Clearday’s Chief Executive Officer, will conduct a 30-minute moderated fireside chat on September 18 at 12:30 PM Eastern time. This Fireside chat will include the opportunity for questions.
The live stream of the Clearday presentation will be available at the following link:
https://www.openexchange.tv/share-series
An archived replay will be available on the SHARE Series website for approximately 90 days following the event
About Clearday™
Clearday™ is an innovative non-acute longevity healthcare services company with a modern, hopeful vision for making high-quality care options more accessible, affordable, and empowering for older Americans and those who love and care for them. Clearday has a decade-long experience in non-acute care , which operates highly-rated residential memory care and adult daycare communities. Its Longevity Care Platform brings Clearday solutions to people wherever they are. Its platform is at the intersection of telehealth, remote monitoring, and patient engagement — all delivered across mobile, wearable, and robotic endpoints in a Software-as-a-Service (SaaS) and Robotics as a Service (RaaS) model.
Forward-Looking Statements
Certain statements made in this Press Release are “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “target,” “believe,” “expect,” “will,” “shall,” “may,” “anticipate,” “assume,” “estimate,” “would,” “could,” “positioned,” “future,” “forecast,” “intend,” “plan,” “project,” “outlook” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on Clearday’s current beliefs, expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Actual results and outcomes may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results and outcomes to differ materially from those indicated in the forward-looking statements include, among others, the following: (1) the occurrence of any event, change, or other circumstances that could give rise to the termination of previously announced expansion of services or strategic transactions; (2) the institution or outcome of any legal proceedings that may be instituted against Clearday; (3) the inability of Clearday to implement its business plans and strategies; (4) the Impact of COVID-19 pandemic on Clearday’s business and/or the ability of the parties to complete the proposed business combination; (5) the possibility that Clearday may be adversely affected by other economic, business, and/or competitive factors; and (6) other risks and uncertainties indicated from time to time in the Clearday’s Annual Report on Form 10-K, including those under “Risk Factors” therein, and in Clearday’s other filings with the SEC. The foregoing list of factors is not exclusive and Clearday cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Clearday does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, whether as a result of new information, future events, or otherwise, except as may be required by applicable law.
No Offer or Solicitation
This Press Release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.
Media Inquiries
Investor Relations
Ginny Connolly
Info@myclearday.com
info@myclearday.com
210-451-0839
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…